Overview

Expanded Access Trial of Plant Expressed Recombinant Glucocerebrosidase (prGCD) in Patients With Gaucher Disease

Status:
No longer available

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

This is an open-label expanded access trial of prGCD in patients with Gaucher disease who require enzyme replacement therapy (ERT) and who have been treated with imiglucerase but for whom the dose has been reduced or discontinued due to shortage of the product.

Details

Lead Sponsor:

Pfizer
Protalix